# A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With Autism

> **NCT01887132** · PHASE2 · TERMINATED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 5 (actual)

## Conditions studied

- Autism Spectrum Disorders

## Interventions

- **DRUG:** Donepezil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01887132
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-06
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2017-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01887132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01887132, "A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With Autism". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01887132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*